defensin
widespread
natur
activ
broad
rang
pathogen
defensin
direct
antimicrobi
effect
also
modul
innat
adapt
immun
respons
consid
role
human
defensin
cathelicidin
defens
respiratori
gastrointestin
genitourinari
tract
oral
caviti
skin
eye
human
hbd
human
defensin
involv
obvious
mucos
respons
produc
princip
epitheli
cell
human
hnp
produc
princip
neutrophil
recruit
mucosa
understand
biolog
defensin
begin
clarifi
pathophysiolog
mucos
inflammatori
infecti
diseas
eg
crohn
diseas
atop
dermat
lung
urinari
infect
challeng
studi
redund
innat
defens
mechan
presenc
interact
mani
innat
defens
protein
mucos
secret
j
leukoc
biol
review
focu
specif
role
defensin
antimicrobi
peptid
human
mucos
immun
excel
recent
review
cover
structur
genom
evolut
mechan
action
antimicrobi
peptid
refer
reader
extens
discuss
aspect
consid
topic
relat
action
antimicrobi
peptid
specif
mucos
site
gener
defensin
two
major
function
host
defens
direct
inhibit
pathogen
modul
innat
adapt
immun
respons
human
defensin
includ
hbd
express
wide
skin
mucos
epithelia
six
includ
hnp
epitheli
hbd
express
predominantli
mucos
epitheli
cell
contribut
initi
host
defens
infect
also
mainten
epitheli
integr
hnp
express
predominantli
neutrophil
lesser
extent
bone
marrowderiv
cell
resid
recruit
inflam
infect
site
bodi
express
constitut
gener
packag
granul
azurophil
granul
neutrophil
hnp
small
intestin
paneth
cell
granul
hd
releas
degranul
hd
also
releas
epitheli
cell
mucos
site
eg
genitourinari
tract
hnp
gener
process
matur
peptid
prior
releas
wherea
hd
must
cleav
extracellular
proteas
achiev
matur
activ
form
gener
hbd
express
secret
epitheli
cell
rather
degranul
secret
matur
form
surfac
line
fluid
surround
cell
consid
hbd
review
although
least
two
other
describ
wide
express
constitut
manner
epitheli
cell
express
induc
small
degre
inflammatori
stimuli
epithelia
hbd
also
wide
express
epitheli
cell
express
induc
tissu
respons
infecti
inflammatori
stimuli
includ
similar
biolog
play
central
role
mucos
defens
well
like
defensin
member
larg
famili
cation
antimicrobi
peptid
express
mani
speci
broadspectrum
antimicrobi
activ
mani
immunomodulatori
effect
cathelicidin
contain
signal
peptid
cathelinlik
domain
antimicrobi
domain
produc
neutrophil
macrophag
variou
epitheli
cell
well
antimicrobi
domain
releas
cleavag
proteas
domain
term
gener
use
term
subsequ
review
also
consid
anoth
class
defensin
call
defensin
retrocyclin
cyclic
structur
express
nonhuman
primat
rhesu
macaqu
oliv
baboon
papio
anubi
human
express
defensin
mrna
lack
correspond
peptid
human
defensin
gene
contain
stop
codon
signal
sequenc
abort
translat
retrocyclin
synthet
human
defensin
peptid
whose
sequenc
base
found
human
defensin
gene
deft
also
broadspectrum
antibacteri
antivir
activ
relev
review
therapeut
potenti
also
shown
recent
express
rescu
human
cervicovagin
epitheli
cell
treatment
aminoglycosid
focu
major
mucos
system
includ
respiratori
tract
gastrointestin
tract
oral
caviti
genitourinari
tract
skin
eye
discuss
respiratori
tract
extens
gener
theme
concept
laid
mucosa
within
system
even
within
differ
local
within
mucos
system
eg
nasal
caviti
upper
lower
respiratori
tract
differ
function
bodi
differ
need
term
host
defens
site
normal
steril
other
contain
commens
bacteria
necess
full
justic
differ
domain
within
mucos
system
divers
role
defensin
play
within
specif
site
howev
hope
convey
extraordinari
detail
intricaci
system
evolv
allow
mucos
surfac
carri
job
allow
exchang
extern
environ
protect
us
myriad
pathogen
potenti
injuri
tabl
summar
major
known
associ
human
diseas
alter
defensin
distinct
featur
respiratori
tract
make
innat
defens
particularli
import
respiratori
epithelium
huge
surfac
estim
size
tenni
court
alveolar
epithelium
particular
must
thin
delic
allow
exchang
oxygen
air
blood
delic
mucosa
must
protect
toxin
infecti
agent
minimum
inflamm
upper
respiratori
tract
function
conduct
air
also
filter
prevent
penetr
particul
infecti
agent
alveoli
clear
defensin
cathelicidin
play
key
role
innat
defens
respiratori
tract
howev
challeng
isol
specif
contribut
result
complex
redund
innat
defens
mechan
evolv
defensin
cathelicidin
produc
respiratori
epitheli
cell
immun
cell
resid
recruit
respiratori
tract
first
consid
role
respiratori
epithelium
per
se
defens
bone
marrowderiv
inflammatori
cell
contribut
defens
interact
epithelium
complex
topic
focu
key
point
semin
find
led
us
current
state
understand
respiratori
epithelium
felt
import
compon
innat
respons
system
lung
infect
shornick
et
al
recent
confirm
import
epithelium
per
se
oppos
bone
marrowderiv
cell
initi
immun
respons
studi
mice
lack
epithelium
bone
marrow
contain
strongli
impair
respons
respiratori
viral
infect
invers
true
diamond
et
al
first
report
product
defensin
tap
respiratori
epitheli
cell
bovin
tracheal
epithelium
tremend
progress
field
sinc
tap
subsequ
shown
member
bd
famili
homologu
induc
nfbdepend
mechan
trigger
bacteria
lp
demonstr
human
respiratori
epitheli
cell
produc
hbd
constitut
express
gener
upregul
wherea
other
upregul
infect
inflamm
peptid
express
varieti
epithelia
broadspectrum
antimicrobi
activ
highli
express
lung
wherea
express
highli
test
stomach
bone
marrow
skin
tonsil
import
question
evalu
depth
rel
level
secret
defensin
differ
level
respiratori
tract
infect
regul
express
respiratori
epitheli
cell
evalu
fairli
extens
induc
lp
manner
involv
nfb
lung
epitheli
cell
express
requir
lp
also
produc
mononuclear
phagocyt
possibl
cell
lack
rsv
also
stimul
product
cell
nfbdepend
process
involv
rsvstimul
gener
cell
induc
bacteria
primari
tracheal
epitheli
cell
recent
studi
demonstr
vitamin
import
regul
express
respiratori
epitheli
cell
convert
vitamin
activ
metabolit
contain
vitamin
receptor
elabor
cathelicidin
respons
activ
metabolit
vitamin
respons
potenti
dsrna
figur
provid
overview
product
hbd
respiratori
epithelia
addit
direct
antimicrobi
antivir
activ
hbd
function
alarmin
stimul
recruit
inflammatori
cell
mucosa
larg
topic
subject
excel
recent
review
brief
hbd
chemotact
dc
cell
via
interact
activ
dc
via
bind
similarli
activ
apc
interact
hbd
also
stimul
mast
cell
migrat
activ
stimul
chemotaxi
neutrophil
monocyt
cell
via
downregul
monocyt
inflammatori
cytokin
product
respons
lp
tlr
ligand
recent
also
shown
bind
gapdh
intracellular
locat
monocyt
lead
gener
chemokin
henc
clear
peptid
contribut
solidifi
initi
mucos
barrier
infect
also
modul
innat
adapt
immun
respons
recruit
neutrophil
mononuclear
phagocyt
bring
play
hnp
increas
peptid
import
direct
antimicrobi
effect
also
signal
properti
addit
complex
interact
phagocyt
epitheli
cell
trigger
respons
epitheli
cell
hnp
produc
abundantli
neutrophil
although
limit
product
eosinophil
report
although
macrophag
store
minor
reduc
level
lesion
hyperig
syndrom
reduc
level
antimicrobi
peptid
product
keratinocyt
associ
atopi
recurr
staphylocc
infect
chronic
skin
ulcer
reduc
antimicrobi
peptid
express
ulcer
psoriasi
increas
lesion
elev
hbd
gene
copi
number
acn
rosacea
increas
lesion
amount
hnp
fascin
recent
paper
demonstr
acquir
hnp
via
ingest
neutrophil
hnp
coloc
mycobacterium
tuberculosi
earli
endosom
contribut
inhibit
bacteri
growth
possibl
find
repres
widespread
phenomenon
defensin
taken
variou
cell
type
exert
inhibit
growth
intracellular
pathogen
exampl
shown
taken
cervic
epitheli
cell
hnp
also
chemotact
effect
immatur
dc
cell
mast
cell
addit
hnp
stimul
mrna
protein
product
human
bronchial
epitheli
cell
high
concentr
gml
hnp
also
cytotox
respiratori
epitheli
cell
induc
mucin
product
cell
addit
increas
presenc
lp
hnp
also
induc
oxid
product
lung
explant
combin
lung
explant
tissu
defensin
markedli
greater
antibacteri
activ
hnp
alon
hnp
also
induc
aggreg
bacteria
virus
promot
uptak
pathogen
neutrophil
macrophag
henc
variou
way
hnp
could
promot
immun
respons
inflamm
lung
also
produc
neutrophil
mononuclear
phagocyt
activ
epitheli
cell
interact
egfr
promot
inflammatori
respons
macrophag
concert
howev
also
bind
lp
inhibit
respons
mechan
direct
interact
monocyt
cell
reduc
tlrmediat
activ
mous
model
help
analysi
role
hbd
mous
homologu
hbd
identifi
follow
cramp
knockout
cramp
gene
accomplish
result
mous
model
develop
two
laboratori
shown
obviou
phenotyp
chang
absenc
infect
absenc
result
delay
clearanc
hemophilu
influenza
lung
although
inflammatori
respons
surviv
unchang
differ
respons
streptococcu
pneumonia
staphylococcu
aureu
lung
infect
note
mice
subtleti
defect
mice
rais
question
whether
delet
sever
mbd
would
need
show
greater
effect
host
defens
defect
document
mice
thu
far
bacteri
infect
skin
urinari
tract
one
limit
mous
model
mous
neutrophil
express
peptid
homolog
hnp
anim
model
use
studi
upregul
mbd
cramp
respiratori
bacteri
infect
viral
infect
also
increas
express
epitheli
defensin
instanc
iav
infect
upregul
express
conduct
airway
epitheli
cell
mice
parainfluenza
viru
increas
express
sheep
neonat
lamb
case
upregul
bd
coincid
increas
express
spd
anoth
innat
immun
protein
broadspectrum
antibacteri
antivir
activ
cf
studi
cf
reveal
complex
tri
determin
role
defensin
lung
diseas
children
cf
born
normal
lung
function
undergo
steadi
deterior
mark
recurr
respiratori
bacteri
viral
infect
chronic
lung
infect
organ
pseudomona
aeruginosa
burkholderia
cenocepacia
balf
cf
patient
shown
reduc
antibacteri
activ
appear
part
result
high
salt
concentr
fluid
inhibit
defensin
activ
saltsensit
upregul
infect
may
impair
cf
level
hbd
hnp
affect
gene
copi
number
highli
variabl
gene
encod
protein
howev
associ
found
hbd
copi
number
progress
cf
hbd
shown
proteolyt
degrad
cathepsin
present
balf
cf
patient
addit
lp
b
cenocepacia
render
resist
antimicrobi
peptid
henc
appear
impair
activ
impair
product
acceler
breakdown
hbd
cf
could
part
account
reduc
antibacteri
activ
saltinsensit
defect
antibacteri
activ
fluid
also
demonstr
furthermor
increas
level
hnp
cf
balf
associ
persist
inflamm
infect
peptid
could
actual
promot
deleteri
inflamm
sever
way
includ
stimul
mucin
product
interf
activ
spd
neutrophil
proteas
level
elev
concert
hnp
cf
inflammatori
lung
condit
eg
defici
act
concert
manner
reduc
spd
level
stimul
product
note
instil
hnp
mous
lung
caus
inflamm
deterior
lung
function
find
suggest
condit
high
level
hnp
may
deleteri
contrast
recent
studi
show
hnp
releas
die
necrot
neutrophil
dampen
inflamm
vitro
vivo
probabl
inhibit
proinflammatori
cytokin
product
macrophag
promot
macrophag
phagocytosi
inflammatori
lung
diseas
elev
level
found
diffus
panbronchiol
progress
inflammatori
diseas
also
associ
recurr
episod
lung
infect
similarli
elev
level
note
bronchiol
obliteran
complic
lung
transplant
elev
level
hnp
found
idiopath
pulmonari
fibrosi
ard
case
correl
degre
lung
inflamm
injuri
studi
obvious
need
determin
defensin
caus
inflamm
respons
insult
contribut
defensin
asthma
studi
extens
although
subject
asthma
increas
suscept
respiratori
viral
infect
interest
express
suppress
cytokin
lead
reduc
antimicrobi
activ
corticosteroid
treatment
also
reduc
antimicrobi
peptid
product
calv
lung
infect
bacteri
pneumonia
associ
elev
level
lung
fluid
blood
consequ
neutrophil
recruit
massiv
amount
hnp
also
present
acut
phase
pneumonia
extent
peptid
act
within
phagocyt
vacuol
releas
respiratori
fluid
determin
howev
high
level
eg
ugml
measur
blood
sepsi
balf
patient
bacteri
pneumonia
tuberculosi
unclear
defensin
process
remov
although
one
mechan
inhibit
hnp
lung
involv
adpribosyl
arginin
residu
hnp
activ
also
inhibit
serum
protein
pathogen
bacteria
evolv
way
evad
kill
respiratori
antimicrobi
peptid
includ
modif
lp
structur
eg
b
cenocepacia
h
influenza
secret
bacteri
surfac
protein
eg
penicillinbind
protein
group
b
streptococcu
appear
play
import
role
host
defens
tuberculosi
african
american
shown
increas
suscept
tuberculosi
may
relat
low
level
vitamin
consequ
reduc
abil
macrophag
kill
tuberculosi
treatment
macrophag
tlr
agonist
increas
vitamin
receptor
result
increas
product
vitamin
drespons
gene
hnp
also
activ
mycobacteria
may
contribut
host
defens
mediat
macrophag
eosinophil
antimicrobi
peptid
like
play
import
role
respiratori
viral
infect
well
hnp
hd
retrocyclin
antivir
activ
iav
interest
treatment
increas
cathelicidin
product
mous
lung
treatment
result
improv
outcom
iav
infect
spd
also
play
import
role
defens
iav
potenti
advers
effect
sever
respiratori
iav
sar
infect
associ
extens
neutrophil
influx
degrad
spd
action
proteas
hnp
hnp
bind
strongli
spd
gener
reduc
antivir
activ
caus
precipit
balf
shown
recent
retrocyclin
hbd
interfer
antivir
activ
spd
rather
addit
effect
defensin
also
activ
varieti
respiratori
virus
includ
rsv
adenoviru
parainfluenza
viru
contribut
respiratori
epitheli
cell
respons
rhinoviru
tobacco
smoke
tobacco
smoke
predispos
infect
emphysema
lung
cancer
recent
studi
demonstr
current
former
smoke
associ
reduc
level
pharyng
wash
sputum
patient
acut
pneumonia
note
smoke
chronic
obstruct
lung
diseas
also
associ
reduc
level
spa
spd
may
impair
innat
defens
compel
vivo
clinic
evid
import
defensin
maintain
mucos
defens
deriv
studi
role
paneth
cell
includ
human
relat
cryptdin
mice
paneth
cell
secretori
cell
present
base
lumin
crypt
small
intestin
cell
degranul
respons
microbi
stimuli
muramyl
peptid
lp
cpg
dna
human
constitut
abund
releas
granul
compon
although
antimicrobi
product
releas
includ
lysozym
trypsin
antitrypsin
murin
studi
point
import
role
paneth
cell
intestin
host
defens
delet
result
impair
product
paneth
cell
defensin
mice
decreas
resist
oral
bacteri
challeng
overexpress
intestin
mice
result
grade
chang
microbi
flora
increas
protect
challeng
salmonella
typhimurium
mice
appear
paneth
cell
earli
life
correl
abil
inhibit
growth
shigella
speci
gut
studi
human
subject
ileal
crohn
diseas
cd
reveal
consist
evid
defici
diseas
pathogenesi
cd
chronic
inflammatori
condit
affect
small
bowel
especi
ileum
colon
lead
strictur
fistula
format
intestin
obstruct
cancer
main
approach
treatment
immun
suppress
surgeri
howev
longstand
observ
antibiot
caus
improv
chang
gut
bacteri
flora
adher
bacteria
small
intestin
line
found
cd
lead
hypothesi
primari
defect
antibacteri
defens
present
lead
chronic
inflamm
major
breakthrough
field
discoveri
link
frameshift
mutat
recruit
domain
subset
patient
cd
highli
express
paneth
cell
cytoplasm
receptor
bacteri
muramyl
peptid
cellwal
compon
mani
bacteria
lead
nfb
activ
product
mutat
associ
mark
defici
link
specif
ileal
cd
colon
cd
ulcer
coliti
mice
show
decreas
subset
cryptdin
increas
suscept
listeria
infect
mutat
provid
genet
mechan
subset
patient
ileal
cd
howev
approxim
onethird
cd
patient
mutat
western
countri
rare
japanes
cd
patient
despit
defici
antibacteri
activ
intestin
mucos
extract
specif
paneth
cell
demonstr
major
patient
ileal
cd
defici
specif
paneth
cell
product
includ
lysozym
affect
find
led
search
explan
paneth
cell
cd
patient
wildtyp
recent
studi
demonstr
defici
ileal
cd
wnt
signal
involv
differenti
matur
paneth
cell
regul
specif
express
paneth
cell
mice
demonstr
mice
decreas
mrna
found
ileal
mucosa
ileal
cd
patient
decreas
correl
decreas
express
associ
express
inflamm
score
level
mutat
subject
defici
specif
ileal
colon
cd
heterozyg
mice
show
decreas
well
decreas
small
intestin
kill
aureu
e
coli
recent
group
demonstr
genet
associ
one
polymorph
promot
region
ileal
cd
genet
associ
independ
statu
henc
alter
appear
provid
anoth
genet
basi
paneth
cell
defici
ileal
cd
interest
associ
decreas
express
copi
number
made
colon
cd
suggest
form
diseas
also
relat
defect
defensinmedi
host
defens
express
induc
colon
mucosa
activ
nfb
contrast
ulcer
coliti
express
elev
area
inflamm
express
elev
colon
cd
lumin
secret
colon
cd
reduc
antimicrobi
activ
similar
pattern
found
colon
cathelicidin
express
increas
inflam
area
ulcer
coliti
increas
colon
cd
henc
colon
cd
may
also
result
local
defici
antimicrobi
peptid
express
impair
epitheli
antibacteri
defens
mice
show
increas
adher
pathogen
intestin
bacteria
gut
support
concept
cathelicidin
contribut
intestin
host
defens
overal
result
highlight
import
defensin
part
initi
barrier
infect
mucos
surfac
appear
like
chronic
intestin
inflamm
character
differ
form
cd
therefor
reflect
simpl
hyperinflammatori
phenotyp
rather
failur
first
line
host
defens
lead
second
level
innat
adapt
immun
respons
fact
less
effect
rais
question
whether
chronic
inflammatori
condit
eg
asthma
result
failur
initi
defens
barrier
stomach
gastrointestin
site
normal
steril
apart
certain
highli
adapt
bacteria
h
pylori
infect
respons
varieti
human
diseas
includ
peptic
ulcer
diseas
gastric
cancer
includ
gastric
lymphoma
adenocarcinoma
human
popul
infect
h
pylori
major
asymptomat
therefor
import
goal
research
determin
factor
respons
colon
diseas
induct
h
pylori
one
import
factor
variat
pathogen
differ
h
pylori
strain
howev
variat
innat
defens
h
pylori
may
also
contribut
h
pylori
induc
hbd
mrna
protein
express
vitro
vivo
gastric
epithelia
strong
bactericid
activ
h
pylori
h
pylori
lp
appear
strong
stimulu
nfb
activ
gastric
epitheli
cell
impli
may
key
pathway
involv
respons
cell
bacteria
boughan
et
al
found
h
pylori
stimul
distinct
mechan
cell
stimul
wherea
upregul
egfrmedi
pathway
cathelicidin
express
also
induc
gastric
epithelia
h
pylori
independ
antimicrobi
activ
bacteria
synerg
hbd
yet
known
event
relat
colon
diseas
induct
h
pylori
result
provid
basi
futur
clinic
research
tempt
specul
impair
earli
defensinmedi
respons
may
allow
colon
ongo
inflamm
similar
find
cd
result
boughan
et
al
also
reveal
complex
regul
differ
defensin
author
specul
may
involv
earli
phase
host
respons
infect
wherea
induct
may
relat
later
woundheal
phase
respons
egfr
upregul
h
pylori
infect
involv
wound
heal
note
express
defensin
mous
intestin
epithelium
correl
abil
inhibit
growth
salmonella
shigella
speci
gut
bacteri
pathogen
also
elicit
defensin
express
variabl
extent
intestin
epithelium
perhap
account
differ
pathogen
import
antimicrobi
peptid
host
defens
intestin
highlight
abil
import
intestin
bacteri
pathogen
counteract
product
action
peptid
exampl
cholera
toxin
labil
toxin
enteropathogen
e
coli
reduc
express
intestin
epitheli
cell
virul
shigella
flexneri
releas
plasmid
dna
turn
express
antimicrobi
peptid
epitheli
cell
monocyt
salmonella
speci
modifi
structur
lp
reduc
abil
antimicrobi
peptid
bind
kill
see
ref
excel
review
topic
role
antimicrobi
peptid
oral
caviti
subject
recent
excel
review
show
intrins
antivir
activ
saliva
iav
part
mediat
hnp
anoth
antimicrobi
peptid
histatin
although
inhibitor
contribut
well
fairli
high
level
hnp
saliva
normal
volunt
presum
deriv
neutrophil
edentul
subject
markedli
reduc
level
hnp
saliva
result
absenc
crevicula
site
neutrophil
ingress
may
account
increas
risk
oral
infect
subject
hiv
also
inhibit
saliva
hiv
appear
transmit
oral
contact
inhibit
hiv
concentr
found
normal
saliva
interest
level
found
reduc
saliva
hivposit
subject
possibl
predispos
type
infect
morbu
kostmann
form
congenit
neutropenia
character
frequent
infect
includ
sever
periodont
although
neutrophil
count
increas
gcsf
treatment
infect
persist
associ
defect
abil
neutrophil
produc
hnp
lack
saliva
femal
reproduct
tract
portal
entri
bacteri
fungal
viral
infect
cervicovagin
secret
contain
mani
innat
inhibitor
could
contribut
host
defens
bacteria
virus
fungi
includ
hnp
hbd
protein
serum
leukocyt
proteas
inhibitor
lysozym
level
hnp
vagin
lavag
normal
control
gml
level
rang
ngml
base
studi
valor
et
al
major
sourc
hnp
probabl
neutrophil
perhap
account
compar
high
concentr
hnp
constitu
cervicovagin
secret
vari
menstrual
cycl
estrogen
treatment
presenc
infect
see
intens
studi
host
defens
factor
may
contribut
protect
vulner
sexual
transmit
viral
infect
cation
antimicrobi
peptid
key
factor
contribut
abil
cervicovagin
secret
inhibit
hiv
interest
direct
hiv
inhibitori
activ
also
bind
downregul
coreceptor
cervicovagin
fluid
healthi
subject
inhibit
hsv
includ
protect
mice
lethal
infect
hsv
wherea
fluid
hivposit
subject
less
inhibitori
inhibit
hsv
correl
level
hnp
fluid
increas
risk
hiv
hsv
infect
presenc
concurr
sexual
transmit
bacteri
viral
infect
bacteri
vaginosi
bv
character
chang
bacteri
flora
vagina
loss
normal
commens
lactobacillu
acquisit
bacteria
gardnerella
vaginali
valor
et
al
demonstr
antimicrobi
activ
vagin
fluid
patient
bv
reduc
bv
fluid
lower
concentr
hbd
hnp
compar
normal
control
patient
vulvovagin
candidiasi
low
level
hnp
correl
reduc
neutrophil
influx
henc
appear
defici
defensin
associ
bv
howev
intrins
defect
case
cd
defensin
level
rose
treatment
bv
low
level
defensin
may
contribut
acquisit
hiv
hsv
subject
reason
low
level
defensin
bv
may
relat
failur
g
vaginali
induc
immun
respons
instanc
g
vaginali
induc
vagin
epitheli
cell
wherea
induc
lactobacillu
jensenii
may
relat
lack
lp
low
concentr
peptidoglycan
coat
g
vaginali
bv
therefor
repres
exampl
commens
flora
provok
balanc
innat
immun
respons
limit
introduct
organ
wherea
superinfect
organ
induc
respons
exampl
bacteria
fail
induc
defensin
respons
allow
bacteria
persist
mucosa
instanc
aureu
strain
chronic
nasal
carrier
found
induc
nasal
mucosa
flexneri
inhibit
antimicrobi
peptid
express
gut
epithelia
henc
acquir
deficit
defensinmedi
barrier
result
bacteri
infect
induc
vagin
secret
male
urethra
respons
infect
note
cleavag
precursor
hd
necessari
acquir
antimicrobi
activ
distinct
method
cleavag
found
studi
urethr
secret
subject
n
gonorrhoea
chlamydia
trachomati
infect
neutrophil
proteas
shown
affect
cleavag
also
produc
vagin
epitheli
cell
respons
n
gonorrhoea
infect
although
hnp
hbd
retrocyclin
inhibit
hiv
surpris
find
actual
increas
hiv
infect
cell
effect
mediat
direct
interact
viru
occur
purifi
peptid
supernat
n
gonorrhoeaeinfect
vagin
epitheli
cell
hivenhanc
effect
occur
hd
concentr
gml
although
level
hd
vagin
lavag
less
lavag
probabl
dilut
consider
local
concentr
may
much
higher
interest
futur
determin
subject
nod
mutat
also
reduc
hd
level
mucos
site
intestin
whether
associ
chang
diseas
suscept
note
hnp
level
consider
higher
urethr
cervicovagin
secret
henc
effect
may
predomin
effect
hd
instanc
urethr
level
hnp
particularli
elev
n
gonorrhoea
infect
gml
respect
find
promot
hiv
infect
unexpect
found
contrast
hd
inhibitori
iav
import
determin
reason
diverg
effect
hd
infect
two
envelop
virus
anoth
paradox
find
cervicovagin
secret
contain
high
level
hnp
contribut
antihiv
activ
fluid
associ
one
studi
increas
risk
hiv
transmiss
relat
fact
sampl
came
subject
sexual
transmit
bacteri
infect
case
factor
promot
hiv
transmiss
presum
outweigh
impact
increas
antimicrobi
peptid
interest
increas
hbd
gene
copi
number
associ
reduc
risk
hiv
infect
preliminari
studi
studi
kind
interest
mice
develop
mice
show
increas
carriag
bacteria
bladder
similarli
mice
greater
suscept
bacteri
urinari
tract
infect
bk
viru
nonenvelop
polyomaviru
establish
lifelong
infect
human
popul
gener
infect
asymptomat
becom
problem
immunocompromis
host
caus
hemorrhag
cystiti
kidney
infect
lead
kidney
transplant
reject
recent
studi
demonstr
act
directli
virion
part
viral
aggreg
note
similarli
report
aggreg
iav
defensin
futur
studi
may
determin
differ
express
account
suscept
subject
complic
bk
infect
immun
suppress
papillomaviru
infect
link
genit
wart
cervic
penil
anal
head
neck
cancer
hnp
shown
strong
antivir
activ
human
papillomavirus
vitro
wherea
hbd
lack
activ
shown
anoth
studi
mediat
recruit
dc
preneoplast
epitheli
lesion
induc
papillomaviru
henc
defensin
may
modul
immun
respons
papillomavirusrel
cancer
preneoplast
lesion
possibl
antimicrobi
peptid
protect
prostat
carcinoma
instanc
prostat
cancer
associ
loss
express
reexpress
induc
cell
death
prostat
cancer
cell
line
contrast
evid
facilit
develop
ovarian
cancer
skin
provid
essenti
barrier
electrolyt
loss
infect
surpris
therefor
skin
heavili
invest
host
defens
peptid
studi
skin
extrem
valuabl
character
regul
role
antimicrobi
peptid
host
defens
wound
heal
barrier
function
hbd
express
epitheli
cell
skin
regul
express
surprisingli
complex
strongli
induc
keratinocyt
distinct
mechan
express
skin
induc
lp
bacteri
product
combin
deriv
resid
monocytederiv
cell
wherea
induct
result
transactiv
egfr
transactiv
refer
local
releas
surfacebound
egfr
ligand
via
activ
metalloproteas
henc
distinct
role
metalloproteas
defensin
biolog
cleavag
defensin
precursor
discuss
previous
increas
express
hbd
respons
egfr
ligand
suggest
defensin
play
role
wound
heal
also
induc
skin
lesser
extent
similar
stimuli
hbd
also
found
distinct
anatom
loci
express
within
skin
find
suggest
differ
hbd
may
distinct
role
respons
skin
infect
injuri
murin
homologu
cramp
also
induc
keratinocyt
skin
wound
increas
skin
wound
mice
manner
coordin
increas
cramp
lipid
metabol
respons
find
consist
fact
antimicrobi
peptid
copackag
lipid
lamellar
bodi
epidermi
furthermor
upregul
antimicrobi
peptid
respons
interrupt
skin
barrier
demonstr
interrelationship
skinbarri
function
wound
heal
defens
infect
mice
develop
impair
restor
skin
barrier
function
wound
also
increas
suscept
streptococc
skin
infect
increas
human
skin
wound
stimul
angiogenesi
promot
wound
heal
differ
signal
mechan
stimul
keratinocyt
migrat
via
transactiv
egfr
activ
endotheli
cell
via
bind
vitamin
critic
regul
cathelicidin
skin
level
markedli
elev
skin
lesion
psoriasi
one
drive
factor
induct
produc
lesion
cell
glucocorticoid
downregul
express
cramp
mous
skin
inhibit
activ
human
keratinocyt
tnf
increas
complex
regul
antimicrobi
peptid
express
skin
relev
varieti
import
skin
diseas
atop
dermat
character
increas
frequenc
skin
infect
viral
bacteri
fungal
organ
express
reduc
greatli
atop
dermat
lesion
compar
normal
control
psoriasi
peptid
increas
decreas
antimicrobi
peptid
express
independ
recent
steroid
use
hyperig
syndrom
primari
immunodefici
subject
atopi
recurr
staphylocc
skin
lung
infect
condit
found
relat
defect
cell
differenti
rais
question
infect
confin
princip
lung
skin
recent
studi
demonstr
may
relat
fact
keratinocyt
bronchial
epitheli
cell
contrast
epithelia
requir
classic
cytokin
gener
chemokin
antimicrobi
peptid
chronic
skin
ulcer
found
low
level
express
well
perhap
reflect
import
wound
heal
note
psoriasi
character
markedli
increas
express
case
may
contribut
diseas
pathogenesi
bind
selfdna
result
autoimmun
respons
direct
dc
interest
hbd
gene
copi
number
increas
psoriasi
serum
level
hbd
propos
marker
diseas
increas
concentr
also
found
promot
inflamm
roseacea
glucocorticoid
elev
result
psycholog
stress
mice
caus
downregul
cramp
mous
skin
result
greater
suscept
streptococc
skin
infect
psycholog
stress
predispos
respiratori
infect
well
would
interest
determin
part
mediat
stressinduc
decreas
antimicrobi
peptid
express
lung
egfr
inhibitor
use
increasingli
treatment
cancer
principl
toxic
dermatolog
includ
acnelik
rash
fissur
skin
interest
determin
toxic
relat
inhibit
defensin
product
skin
eye
anoth
site
effect
firstlin
host
defens
minim
inflamm
import
p
aeruginosa
import
organ
capabl
caus
destruct
infect
cornea
use
mous
model
corneal
infect
pseudomona
infect
found
import
reduc
bacteri
count
neutrophil
infiltr
also
modul
express
varieti
inflammatori
cytokin
reduc
nfb
activ
although
also
express
cornea
silenc
alter
infect
inflamm
tear
fluid
also
contain
spd
inhibit
p
aeruginosa
infect
mice
henc
anoth
site
like
respiratori
tract
spd
defensin
may
interact
eye
also
potenti
portal
entri
iav
site
viral
infect
applic
defensin
shown
protect
hsvinduc
kerat
although
discuss
depth
potenti
therapeut
use
defensin
possibl
relev
review
defensin
potenti
therapi
given
broadspectrum
antimicrobi
antivir
activ
fact
synthes
minor
modif
enhanc
activ
direct
applic
site
skin
cervicovagin
mucosa
treatment
wound
infect
interest
particularli
condit
antimicrobi
peptid
gener
reduc
one
concern
direct
applic
defensin
would
possibl
induc
excess
inflamm
occur
instil
hnp
lung
retrocyclin
interest
hiv
therapi
strongli
inhibit
viral
replic
found
retrocyclin
strong
antivir
activ
iav
unlik
hnp
interfer
antivir
activ
spd
despit
bind
henc
retrocyclin
may
better
candid
hnp
instil
respiratori
tract
recent
studi
demonstr
reduc
weight
loss
mortal
mice
treat
retrocyclin
intranas
instil
min
infect
mouseadapt
version
sar
coronaviru
surprisingli
protect
result
inhibit
viral
replic
model
retrocyclin
induc
level
inflamm
lung
although
reduc
gener
proinflammatori
cytokin
trigger
viru
henc
retrocyclin
may
exert
benefici
effect
modul
inflammatori
respons
lung
anoth
fascin
recent
find
retrocyclin
produc
human
cervicovagin
secret
respons
aminoglycosid
treatment
treatment
diseas
direct
applic
defensin
may
impract
eg
deliv
defensin
treatment
inflammatori
bowel
diseas
adenovir
vector
deliveri
antimicrobi
peptid
test
anim
model
mix
result
anoth
approach
would
increas
endogen
defensin
gener
use
known
regulatori
stimuli
mous
model
administr
increas
defensin
cathelicidin
gener
improv
outcom
iav
infect
vascular
endotheli
growth
factor
promot
bd
spd
product
lung
result
improv
outcom
rsv
infect
import
vitamin
gener
aspect
innat
defens
indic
measur
vitamin
level
supplement
could
import
improv
outcom
infect
one
gener
theme
emerg
studi
defensin
firstlin
host
defens
protein
success
initi
barrier
invas
pathogen
prevent
deleteri
inflamm
breakdown
function
initi
barrier
lead
infect
also
chronic
inflammatori
condit
obviou
inflammatori
bowel
diseas
could
account
varieti
condit
gastric
diseas
induc
h
pylori
inflammatori
diseas
lung
interest
regard
bd
imbed
physiolog
process
wound
heal
angiogenesi
addit
role
defens
infect
reminisc
role
surfact
protein
lung
phospholipid
metabol
well
host
defens
anoth
recur
theme
pathogen
bacteria
evolv
varieti
mechan
circumv
defensinmedi
immun
creat
invas
infect
import
subject
futur
studi
includ
defensin
interact
compon
innat
defens
sinc
clearli
act
isol
preliminari
studi
explor
question
studi
need
furthermor
current
hard
determin
rel
import
direct
antimicrobi
antivir
effect
defensin
compar
immunomodulatori
effect
mani
instanc
henc
import
focu
futur
investig
